EPISODE · Nov 22, 2022 · 43 MIN
Tesla’s technicals, biotech’s bounce and trading stocks at 52-week highs. 11/22/22
from Power Lunch · host CNBC
Tesla’s stock has been cut in half this year, trading way below the average Wall Street price target. A technician tells us where she thinks the stock goes next. Plus, money has been rotating into biotech stocks. Is the sector recession proof? And the trade on IBM as the stock hits a 52-week high. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Tesla’s stock has been cut in half this year, trading way below the average Wall Street price target. A technician tells us where she thinks the stock goes next. Plus, money has been rotating into biotech stocks. Is the sector recession proof? And the trade on IBM as the stock hits a 52-week high.
NOW PLAYING
Tesla’s technicals, biotech’s bounce and trading stocks at 52-week highs. 11/22/22
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.